BrightFocus Alzheimer's Fast Track 2018

Alzheimer's Fast Track 2018 Group Photo

Co-chairs: Frank LaFerla, PhD, Cynthia Lemere, PhD & Harry Steinbusch, PhD

October 31 - November 2, 2018
Catamaran Resort Hotel
3999 Mission Boulevard
San Diego CA 92109

Graduate students, postdoctoral fellows, or other early-stage scientists focusing on Alzheimer’s disease research, took advantage of this unique opportunity to accelerate their knowledge immersion towards becoming an expert in this exciting field by:

  • Connecting with preeminent Alzheimer’s disease experts and fellow early-stage researchers based in the U.S. and around the world
  • Participating in interactive workgroups and breakout sessions
  • Engaging in scientific debates

Organized by BrightFocus Foundation, Alzheimer’s Fast Track® was a satellite event of the Society for Neuroscience’s annual meeting, in San Diego, California.


Speakers

We have gathered world-renowned experts who will discuss the latest trends in Alzheimer's disease research. The following represents a list of speakers and topics:

  • Paul Aisen, MD, University of Southern California
    Is it Feasible to One Day Prevent AD?

  • Elizabeth M. Bradshaw, PhD, Columbia University
    Innate Immunity in AD, Human and Mouse Blood Samples, Big Data

  • Roberta Diaz Brinton, PhD, The University of Arizona Health Sciences
    Sex Differences in Onset of Prodromal Phase of Alzheimer’s Disease

  • Charles Glabe, PhD, University of California, Irvine
    Conformational Diversity of Amyloid in Alzheimer’s Disease

  • Joshua Grill, PhD, University of California, Irvine
    Challenges in Alzheimer’s Disease Clinical Trials

  • Lea T. Grinberg, MD, PhD, University of California, San Francisco
    Sex Differences in AD: From Clinical Indicators in Aging to iPCs

  • Elizabeth Head, PhD, University of Kentucky
    Predictive Biomarkers for Dementia in Down Syndrome

  • James Hicks, PhD, University of California, Irvine
    Evidence-Based Research on Exercise and Prevention of AD and Related Dementias

  • Edward H. Koo, MD, University of California, San Diego
    Modelling Abeta toxicity: All models are bad but some can be useful

  • Frank M. LaFerla, PhD, University of California, Irvine
    • General Overview of AD models
    • How to Set Up a Lab When Starting Your Career: Navigating Around Potential Pitfalls for Early-Career Investigators
  • Bruce T. Lamb, PhD, Indiana University
    MODEL-AD

  • Prof. Dr. Eckhard Mandelkow, DZNE, German Center for Neurodegenerative Diseases
    Tau: Structure, Aggregation, and Interaction Partners

  • Dr. Eva-Maria Mandelkow, DZNE, German Center for Neurodegenerative Diseases
    Tau: Animal Models, Modes of Toxicity, and Therapeutic Approaches

  • Bri McWhorter, Activate to Captivate
    How to Construct Slides that have Impact, and Make an Impact with Your Speech and Style

  • Prof dr. Trichur R Raju, Natl Inst Mentl Hlth Neuroscience, Bangalore, India
    Yoga, Meditation, and Stress Reduction Influences for AD Rrisk

  • Dr. Subhojit Roy, MD, PhD, University of Wisconsin-Madison
    The Promise of CRISPR/CAS for Alzheimer’s Disease

  • Harry W.M. Steinbusch, PhD, Maastricht University, The Netherlands
    Epigenetic Dysregulation in Aging and Alzheimer's Disease

  • Li-Huei Tsai, Ph.D., Massachusetts Institute of Technology
    iPSC and Epigenetics

  • Michael Yassa, PhD, University of California, Irvine
    Biomarkers for AD

Workshop Goals

The Alzheimer’s disease research field continues to grow in size and scope. For people entering such a prolific environment, acquiring an initial understanding of the disease becomes more difficult each year. The goal of this workshop is to offer graduate students and postdocs an immersive opportunity to learn and discuss some of the latest trends in Alzheimer’s disease research through close interaction with established leaders in the field.

Workshop sessions emphasize open discussion between students and lecturers, and immediate application of new knowledge. Students will participate in faculty-led exercises such as debate and mock grant proposals.

We hope you agree that this is an important and cost-effective opportunity to build knowledge and professional contacts in the Alzheimer’s disease field.


Coordinating Office:

BrightFocus Foundation

  • Stacy Haller, President and CEO
  • Diane Bovenkamp, PhD, Vice President for Scientific Affairs
  • Kara Summers, Scientific Program Grants Manager

Watch this video from BrightFocus Alzheimer’s Fast Track® 2016

BrightFocus Alzheimer's Disease Fast Track®: San Diego, California (November 2016)

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me informed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.